Detail
Článek
Článek online
FT
Medvik - BMČ
  • Je něco špatně v tomto záznamu ?

Pelvic lymphadenectomy improves survival in patients with cervical cancer with low-volume disease in the sentinel node: a retrospective multicenter cohort study

A. Zaal, RP. Zweemer, M. Zikán, L. Dusek, D. Querleu, F. Lécuru, AS. Bats, R. Jach, L. Sevcik, P. Graf, J. Klát, G. Dyduch, S. von Mensdorff-Pouilly, GG. Kenter, RH. Verheijen, D. Cibula,

. 2014 ; 24 (2) : 303-11.

Jazyk angličtina Země Spojené státy americké

Typ dokumentu časopisecké články, multicentrická studie

Perzistentní odkaz   https://www.medvik.cz/link/bmc15008409

OBJECTIVE: In this study, we aimed to describe the value of pelvic lymph node dissection (LND) after sentinel lymph node (SN) biopsy in early-stage cervical cancer. METHODS: We performed a retrospective multicenter cohort study in 8 gynecological oncology departments. In total, 645 women with International Federation of Gynecology and Obstetrics stage IA to IIB cervical cancer of squamous, adeno, or adenosquamous histologic type who underwent SN biopsy followed by pelvic LND were enrolled in this study. Radioisotope tracers and blue dye were used to localize the sentinel node, and pathologic ultrastaging was performed. RESULTS: Among the patients with low-volume disease (micrometastases and isolated tumor cells) in the sentinel node, the overall survival was significantly better (P = 0.046) if more than 16 non-SNs were removed. No such significant difference in survival was detected in patients with negative or macrometastatic sentinel nodes. CONCLUSIONS: Our findings indicate that in patients with negative or macrometastatic disease in the sentinel nodes, an additional LND did not alter survival. Conversely, our data suggest that the survival of patients with low-volume disease is improved when more than 16 additional lymph nodes are removed. If in a prospective trial our data are confirmed, we would suggest a 2-stage operation.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc15008409
003      
CZ-PrNML
005      
20160613092858.0
007      
ta
008      
150306s2014 xxu f 000 0|eng||
009      
AR
024    7_
$a 10.1097/IGC.0000000000000043 $2 doi
035    __
$a (PubMed)24407577
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxu
100    1_
$a Zaal, Afra $u *Division of Woman and Baby, Department of Gynaecological Oncology, University Medical Center Utrecht, Utrecht, The Netherlands; †Department of Obstetrics and Gynecology, Gynecological Oncology Centre, First Faculty of Medicine and General University Hospital, Charles University, Prague; ‡Institute of Biostatistics and Analyses, Masaryk University, Brno, Czech Republic; §Institut Claudius Regaud, Toulouse; ∥Université Paris Descartes, Sorbonne Paris Cité, Assistance Publique-Hôpitaux de Paris, European Georges-Pompidou Teaching Hospital, Paris, France; ¶Jagiellonian University Medical College, Krakow, Poland; #University Hospital Ostrava, Ostrava, Czech Republic; and **Center for Gynaecologic Oncology Amsterdam, VU University Medical Center, Amsterdam, The Netherlands.
245    10
$a Pelvic lymphadenectomy improves survival in patients with cervical cancer with low-volume disease in the sentinel node: a retrospective multicenter cohort study / $c A. Zaal, RP. Zweemer, M. Zikán, L. Dusek, D. Querleu, F. Lécuru, AS. Bats, R. Jach, L. Sevcik, P. Graf, J. Klát, G. Dyduch, S. von Mensdorff-Pouilly, GG. Kenter, RH. Verheijen, D. Cibula,
520    9_
$a OBJECTIVE: In this study, we aimed to describe the value of pelvic lymph node dissection (LND) after sentinel lymph node (SN) biopsy in early-stage cervical cancer. METHODS: We performed a retrospective multicenter cohort study in 8 gynecological oncology departments. In total, 645 women with International Federation of Gynecology and Obstetrics stage IA to IIB cervical cancer of squamous, adeno, or adenosquamous histologic type who underwent SN biopsy followed by pelvic LND were enrolled in this study. Radioisotope tracers and blue dye were used to localize the sentinel node, and pathologic ultrastaging was performed. RESULTS: Among the patients with low-volume disease (micrometastases and isolated tumor cells) in the sentinel node, the overall survival was significantly better (P = 0.046) if more than 16 non-SNs were removed. No such significant difference in survival was detected in patients with negative or macrometastatic sentinel nodes. CONCLUSIONS: Our findings indicate that in patients with negative or macrometastatic disease in the sentinel nodes, an additional LND did not alter survival. Conversely, our data suggest that the survival of patients with low-volume disease is improved when more than 16 additional lymph nodes are removed. If in a prospective trial our data are confirmed, we would suggest a 2-stage operation.
650    _2
$a dospělí $7 D000328
650    _2
$a senioři $7 D000368
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a lidé $7 D006801
650    12
$a lymfadenektomie $7 D008197
650    _2
$a lymfatické uzliny $x patologie $7 D008198
650    _2
$a lidé středního věku $7 D008875
650    _2
$a pánev $x patologie $x chirurgie $7 D010388
650    _2
$a retrospektivní studie $7 D012189
650    _2
$a přežití $7 D013534
650    _2
$a nádory děložního čípku $x patologie $x chirurgie $7 D002583
655    _2
$a časopisecké články $7 D016428
655    _2
$a multicentrická studie $7 D016448
700    1_
$a Zweemer, Ronald P
700    1_
$a Zikán, Michal
700    1_
$a Dusek, Ladislav
700    1_
$a Querleu, Denis
700    1_
$a Lécuru, Fabrice
700    1_
$a Bats, Anne-Sophie
700    1_
$a Jach, Robert
700    1_
$a Sevcik, Libor
700    1_
$a Graf, Petar
700    1_
$a Klát, Jaroslav $7 osd2016913393
700    1_
$a Dyduch, Grzegorz
700    1_
$a von Mensdorff-Pouilly, Silvia
700    1_
$a Kenter, Gemma G
700    1_
$a Verheijen, René H M
700    1_
$a Cibula, David
773    0_
$w MED00009896 $t International journal of gynecological cancer official journal of the International Gynecological Cancer Society $x 1525-1438 $g Roč. 24, č. 2 (2014), s. 303-11
856    41
$u https://pubmed.ncbi.nlm.nih.gov/24407577 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20150306 $b ABA008
991    __
$a 20160613093028 $b ABA008
999    __
$a ok $b bmc $g 1065682 $s 891209
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2014 $b 24 $c 2 $d 303-11 $i 1525-1438 $m International journal of gynecological cancer $n Int J Gynecol Cancer $x MED00009896
LZP    __
$a Pubmed-20150306

Najít záznam

Citační ukazatele

Nahrávání dat ...

Možnosti archivace

Nahrávání dat ...